[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:chronic-hepatitis-b:hepatitis-b-infection":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Chronic Hepatitis B","Hepatitis B Infection",3,[8,16,22],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06963710","A Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg- Negative Adult Subjects With Chronic Hepatitis B (B-SUPREME)",[12],"Phase 2","RECRUITING","2026-08-03T01:56:45.025842Z","2026-05-05T02:43:28.740314Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07654283","Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions",[12],"2026-08-26T02:16:39.977107Z","2026-06-17T19:21:16.688868Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT06154278","Intrahepatic and Peripheral Responses to Imdusiran (AB-729) in Chronic Hepatitis B",[12],"2026-08-26T02:19:13.549512Z","2026-05-05T02:43:27.958288Z"]